On May 21, S&P Global, an international authoritative rating agency, held the "Launch Ceremony and Forum on Sustainable Development of the Sustainable Development Yearbook (China Version) 2026" in Shanghai. Genertec Universal Medical (02666. HK), by virtue of its outstanding performance in the sustainable development assessment (CSA), was rated as the "best 1%" enterprise of the Sustainable Development Yearbook (China Version) 2026, adding another international medal to the company's sustainable development construction process.

The S&P Global Sustainability Yearbook is one of the most influential corporate sustainability assessments in the world, selecting benchmark companies based on a rigorous CSA evaluation system. In 2026, the selection covers 59 industries and over 9200 companies worldwide, with only 848 companies selected and a total of 57 Chinese companies.

Universal Medical made it onto the Chinese version of the "Best 1%" list of enterprises with excellent scores of 66 points for CSA and 68 points for ESG in 2025, and was listed in the global version of the yearbook for the first time.

Behind this achievement is the systematic result of the company's deep cultivation of ESG practices and the establishment of a solid foundation for sustainable development during the 14th Five-Year-Plan period. At the same time, Universal Medical has also been listed in the CCTV ESG Pioneer Series for three consecutive years, and Hang Seng's sustainable development rating has jumped to A-level, and it has won many authoritative awards such as the "Green and Sustainable Contribution Award" from the Hong Kong Quality Assurance Bureau.

During the 14th Five-Year Plan period, Universal Medical underwent a profound transformation in its ESG practices — shifting from trial and error to systematic implementation, and from passive compliance to active innovation.

As a centrally-administered state-owned enterprise, the company remains firmly committed to its responsibilities, keeping the nation’s top priorities in mind. It supports the building of a “Healthy China” through its business operations, ensuring that development gains reach the people more effectively.

Leveraging the synergies of industry and finance, Universal Medical places medical services at its core, backed by financial services and driven by health technology, to create a shared and mutually beneficial big health ecosystem.

On the environmental front, it adopts a twin‑engine approach — green finance and low‑carbon healthcare — to facilitate the rollout of sustainable financial products and channel investment into clean energy, green transportation, and other sectors.

On the social side, the company engages in medical‑related public welfare initiatives, including health science outreach, health technology development, and charitable assistance, thereby building a high‑quality healthcare brand for central SOEs.

As the 15th Five-Year Plan period begins, Universal Medical will continue to be guided by its ESG strategy. With innovation in mechanisms as a key driver and solid ESG practices as a foundation, the company will fully leverage the synergies between industry and finance to build a win-win health ecosystem. It aspires to pioneer ESG governance and sustainable development, contributing China’s wisdom and the strength of a central SOE to global sustainability efforts.